Open Access Green as soon as Postprint is submitted to ZB.
Comparison of the automated KRYPTOR chromogranin A assay with the DAKO ELISA.
Clin. Lab. 60, 2103-2106 (2014)
Background: Currently available assays for the widely used marker for neuroendocrine tumors chromogranin A have a weak comparability, involve manual work, and require batch processing of the samples. In this study, we evaluated the automated chromogranin A KRYPTOR assay compared with the widely used DAKO ELISA. Methods: 83 samples were measured with the DAKO ELISA (EDTA plasma) and the KRYPTOR assay (serum), since different sample materials are recommended. Furthermore, different sample materials were compared. Results: The results between the two assays were highly correlated KRYPTOR serum (ng/mL) = 2.887 ELISA EDTA (U/L) + 5.028; r = 0.99). The inter-assay variation for the KRYPTOR assay was determined as 5.56% at low (95 ng/mL; n = 34) and 6.21% at high (530 ng/mL; n = 33) chromogranin A concentrations. EDTA plasma samples revealed significantly lower results than serum in the KRYPTOR assays and could not be used. Conclusions: In conclusion, the new chromogranin A KRYPTOR assay is fast, reliable, and compares well to an established test after adaptation of sample material and reported units.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
1.084
0.480
4
3
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Chromogranin A ; Assay ; Kryptor ; Tumor Marker; Tumors
Language
english
Publication Year
2014
HGF-reported in Year
2015
ISSN (print) / ISBN
1433-6510
Journal
Clinical Laboratory
Quellenangaben
Volume: 60,
Issue: 12,
Pages: 2103-2106
Publisher
Clinical Laboratory Publ.
Publishing Place
Mainz
Reviewing status
Peer reviewed
POF-Topic(s)
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502400-001
PubMed ID
25651748
WOS ID
WOS:000347667300021
Erfassungsdatum
2015-02-16